Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 IKCS: Europe
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Treatment Toxicities and Symptom Management
Home
Treatment Toxicities and Symptom Management
Treatment Toxicities and Symptom Management
Type here to filter the list
22: Characterization and Management of Adverse Reactions in Patients With Advanced Renal Cell Carcinoma Receiving Lenvatinib + Pembrolizumab (CLEAR Study)
Favorite